Obesity and inactivity are responsible for 30,000 deaths per year in England and 365,000 deaths per year in the US. The incidence of class III obesity (body mass index of 40 or above) is increasing at a rapid rate, and this has resulted in an increase in bariatric operations worldwide. In large-scale prospective trials, obesity surgery has been shown to result in improved quality of life and a decreased risk of death for people of all ages with class III obesity. Studies demonstrate that children and adolescents with class III obesity benefit from weight loss surgery. Patients with class II (body mass index of 35 to 39.9) to class III obesity should undergo a comprehensive assessment and receive care in the immediate and distant postoperative course from weight loss surgery.
Bariatric surgery (also referred to as metabolic surgery) is also being investigated as a possible primary therapy for type 2 diabetes. Results from randomised controlled trials and systematic reviews with meta-analyses have shown superior glycaemic control with bariatric surgery compared with conventional medical therapy alone in people with obesity and type 2 diabetes. Furthermore, guidelines from the American Diabetes Association, the UK-based National Institute for Health and Care Excellence, and the International Diabetes Foundation recommend the use of bariatric surgery in people with obesity and type 2 diabetes who have inadequate glycaemic control on optimal medical therapy alone.
In one small randomised trial, bariatric surgery reduced the number of antihypertensive medications (≥30%) required to maintain blood pressure control in people with obesity and hypertension compared with medical therapy alone.
After bariatric surgery, patients may present to clinics, emergency departments, or a hospital other than the one where they had the operation. Thus, knowledge of common complications is necessary. The abdomen with central adiposity may be difficult to examine and can mask typical signs of sepsis. Careful attention to vital signs, examination findings, and any deviation from expected post-operative course is essential.
In order to help patients sustain weight loss after bariatric surgery, regular self-monitoring and frequent postoperative follow-up visits may be required.
- Types of surgical procedures
- Expected weight loss
- Gastric bypass: description
- Gastric bypass: early complications
- Gastric bypass: late complications
- Gastric band: description
- Gastric band: early complications
- Gastric band: late complications
- Biliopancreatic diversion (BPD) with or without duodenal switch: description
- Biliopancreatic diversion (BPD) with or without duodenal switch: complications
- Sleeve gastrectomy: description
- Sleeve gastrectomy: complications
- Vertical banded gastroplasty (VBG)
- Jejunoileal bypass
- Metabolic and nutritional complications
- Bone and mineral metabolism
- Bariatric surgery and the pregnant patient
- Weight loss failure or weight regain following bariatric surgery
- Abdominal pain following bariatric surgery
- Nausea and vomiting following bariatric surgery
Fatima Cody Stanford, MD, MPH, MPA
Obesity Medicine Physician Medicine
Gastrointestinal Unit, Department of Medicine
Division of Endocrinology, Department of Pediatrics
Massachusetts General Hospital/Harvard Medical School
FCS is the author of an article cited in the topic.
Dr Fatima Cody Stanford would like to gratefully acknowledge Dr Abeezar Sarela and Dr Daniel M. Herron, previous contributors to this topic. AS has no competing interests. DMH has received educational grants from Ethicon Endosurgery and Covidien. DMH has acted as consultant for USGI Medical, Virtual Incision, and Hourglass Technology.
David Arterburn, MD
Group Health Center for Health Studies
DA declares that he has no competing interests.
Evangelos Efthimiou, MBBS, MRCS
Consultant in Bariatric and General Surgery
Chelsea and Westminster Hospital
EE has been sponsored by Ethicon UK in a fellowship grant and has received sponsorship to attend conferences. EE has received speaking fees from Nestle UK.
Dara P. Schuster, MD, FACE
Internal Medicine and Pediatrics
Associate Medical Director
Chronic Disease Management
Ohio State University Hospitals
DPS declares that she has no competing interests.
Hutan Ashrafian, MBBS, MRCS
Clinical Lecturer in Surgery
Imperial College London
HA declares that he has no competing interests.
Use of this content is subject to our disclaimer